The frequency of APOE ε4 exceeds 40% among individuals diagnosed with Alzheimer’s disease but varies among populations—ranging from 9% to 20% in Caucasian, Japanese, African American, and Hispanic groups [56]. Here, APOE is linked to Alzheimer disease.